Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed Press Release on the Financial Results of the Company for the quarter ended June 30, 2023.
The above information is a part of company’s filings submitted to BSE.